Governance Biogen Inc.

BIIB

US09062X1037

Prodotti farmaceutici

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 06/02/2026			Variaz. 5gg	Var. 1 gen.
201,18 ^USD	+8,53%		+11,84%	+14,31%

03:06	Biogen annuncia che la domanda di autorizzazione all'immissione in commercio per la formulazione sottocutanea di Leqembi per il trattamento dell'Alzheimer precoce è stata designata per la Revisione Prioritaria in Cina	RE
06/02	BIOGEN INC. : Stifel Nicolaus è per il Buy	ZM

Comitato esecutivo: Biogen Inc.

Manager

Posizioni ricoperteDa

Christopher Viehbacher

65 anni

Chief Executive Officer	14/11/2022
President	14/11/2022

Susan Alexander

69 anni

General Counsel

01/01/2006

Sean Godbout

51 anni

Comptroller/Controller/Auditor

01/01/2007

Timothy Power

Investor Relations Contact

09/12/2024

Jane Grogan

59 anni

Chief Tech/Sci/R&D Officer

02/10/2023

Nicole Murphy

Chief Operating Officer	01/02/2022
Chief Tech/Sci/R&D Officer	01/02/2022

Priya Singhal

58 anni

Chief Tech/Sci/R&D Officer	15/03/2024
Corporate Officer/Principal	-

Wendell C. Taylor

General Counsel	-
Corporate Secretary	-

Michael Dambach

59 anni

Treasurer

01/01/2010

Robin Kramer

60 anni

Director of Finance/CFO

01/03/2025

Ginger Gregory

58 anni

Human Resources Officer

07/07/2017

Composizione del Consiglio di amministrazione: Biogen Inc.

Amministratore

ComitatiDa

Caroline Dorsa

66 anni

Governance Committee Chair
Audit Committee	06/05/2021
Compensation Committee	01/01/2010
Audit Committee Chair	02/12/2019
Governance Committee	02/12/2019
Nominating Committee	02/12/2019

Eric Rowinsky

69 anni

Governance Committee	01/01/2010
Nominating Committee
Compensation Committee	01/01/2010
Nominating Committee Chair

Maria Freire

71 anni

Governance Committee
Nominating Committee	09/05/2012
Governance Committee Chair
Compensation Committee	02/06/2021

Richard Mulligan

72 anni

Compensation Committee	01/01/2009
Governance Committee	06/05/2022
Nominating Committee	06/05/2022

William Hawkins

72 anni

Governance Committee
Nominating Committee	01/09/2020
Audit Committee Chair

Stephen Sherwin

77 anni

Audit Committee	09/12/2011
Finance Committee	01/01/2010

Jesus Mantas

57 anni

Compensation Committee Chair

19/06/2019

Susan Langer

35 anni

Compensation Committee

Monish Patolawala

56 anni

Audit Committee

01/01/2024

Lloyd Minor

68 anni

Audit Committee

Menelas Nicolas Pangalos

59 anni

Compensation Committee

Christopher Viehbacher

65 anni

Director/Board Member

14/11/2022

Ultime nomine: Biogen Inc.

16/01	Arch Biopartners Inc. annuncia la nomina di Patrick Vink come Presidente del Consiglio di Amministrazione e il pensionamento di Claude Allary dal Consiglio di Amministrazione	CI
12/01	Disc Medicine Inc nomina Lisa Amaya Price come Chief Human Resources Officer	CI
01/12	Tyra Biosciences nomina Heather Faulds come Chief Regulatory Officer, in carica dall'8 dicembre 2025	CI
21/10/25	Climb Bio, Inc. annuncia nuove nomine esecutive	CI
22/09/25	Mallinckrodt plc annuncia cambiamenti ai vertici aziendali	CI
26/08/25	Innovent Biologics nomina Stephen A. Sherwin come Consigliere Indipendente Non Esecutivo e Membro del Comitato Strategico a partire dal 26 agosto 2025	CI
16/07/25	Satellos Bioscience Inc. nomina Wildon Farwell come Chief Medical Officer	CI

Altre notizie

Ex dirigenti e amministratori: Biogen Inc.

Insider

Posizioni ricoperte

DaA

Alexander Denner

Director/Board Member	04/06/2009	26/06/2023
Independent Dir/Board Member	04/06/2009	26/06/2023

Stelios Papadopoulos

Director/Board Member	01/07/2008	12/06/2014
Chairman	12/06/2014	26/06/2023
Independent Dir/Board Member	12/06/2014	26/06/2023

Brian Posner

Director/Board Member	23/07/2008	15/05/2022
Independent Dir/Board Member	23/07/2008	15/05/2022

Robert W. Pangia

Director/Board Member	01/01/1997	02/06/2021
Independent Dir/Board Member	01/01/1997	02/06/2021

Lynn Schenk

Director/Board Member	01/01/1995	03/06/2020
Independent Dir/Board Member	01/01/1995	03/06/2020

Paul Clancy

Director of Finance/CFO	01/01/2003	13/06/2017
Corporate Officer/Principal	-	-
Sales & Marketing	01/01/2001	01/01/2003

William Young

Director/Board Member	12/11/2003	05/01/2010
Chairman	05/01/2010	12/06/2014
Independent Dir/Board Member	20/07/2011	12/06/2014

Keith Regnante

Public Communications Contact

01/01/1999

01/08/2013

Michael Lytton

Corporate Officer/Principal

30/04/2009

01/02/2011

Eric S. Hoffman

Public Communications Contact	01/01/2006	01/03/2010
Corporate Officer/Principal	01/03/2010	01/01/2011

Robert A. Hamm

Chief Operating Officer	31/03/2009	31/12/2010
Corporate Officer/Principal	01/11/2003	31/03/2009

Elizabeth Woo

Public Communications Contact

01/01/1998

Marijn Dekkers

Director/Board Member

06/06/2007

31/12/2009

Cecil B. Pickett

Chief Tech/Sci/R&D Officer

12/07/2006

12/03/2009

Phillip Sharp

Director/Board Member	01/11/2003	15/07/2009
Founder	01/01/1978	15/07/2009

Alan B. Glassberg

Director/Board Member

01/01/1997

01/06/2009

Hans-Peter Hasler

Chief Operating Officer

01/11/2003

30/03/2009

Ted Llana

Corporate Officer/Principal

01/11/2008

Faheem Hasnain

Corporate Officer/Principal

01/10/2004

01/09/2008

Alessandra Cesano

Corporate Officer/Principal

01/01/2006

01/01/2008

David Parkinson

Corporate Officer/Principal

01/09/2007

Mary L. Good

Director/Board Member

01/01/1997

31/05/2007

Alan Belzer

Director/Board Member

01/01/1997

31/05/2007

Arturo Molina

Corporate Officer/Principal

01/07/2003

01/05/2007

Andrew de Guttadauro

Corporate Officer/Principal

01/02/2007

Robert Peach

Corporate Officer/Principal

01/01/2005

Steven Perrin

Corporate Officer/Principal

01/11/2001

01/12/2006

Robert L. de Jager

Chief Tech/Sci/R&D Officer

01/05/2006

01/11/2006

Philip Gotwals

Corporate Officer/Principal

01/08/2004

01/09/2006

Matthew Onaitis

Corporate Officer/Principal

01/01/2006

01/05/2006

Michael LaBarre

Corporate Officer/Principal

01/12/2003

01/04/2006

Katherine J. Turner

Corporate Officer/Principal

01/07/2001

01/11/2005

Michael Gilman

Chief Tech/Sci/R&D Officer	01/05/1999	-
Corporate Officer/Principal	01/03/2012	01/06/2013

Christine Anna White

Chief Tech/Sci/R&D Officer

01/01/1996

01/01/2005

Anne Cook

General Counsel

01/01/1992

01/01/2005

Dinah Sah

Chief Tech/Sci/R&D Officer

01/01/1999

01/01/2005

William R. Rohn

Chief Operating Officer

01/11/2003

01/01/2005

Douglas A. Abel

Corporate Officer/Principal

01/08/2000

01/11/2004

Melissa Morandi

Compliance Officer

01/09/2002

01/03/2004

Nicolas Barthelemy

Corporate Officer/Principal

01/02/1996

01/02/2004

David Hallal

Sales & Marketing

01/08/2002

01/02/2004

Pratik Multani

Chief Tech/Sci/R&D Officer

01/01/1999

01/01/2004

David Mitchell

General Counsel

01/01/2000

01/01/2004

Thomas F. Keller

Director/Board Member

01/11/2003

Lawrence C. Best

Director/Board Member

01/11/2003

Carol Gallagher

Sales & Marketing

01/01/2002

01/11/2003

Michael D. Kowolenko

Chief Tech/Sci/R&D Officer

01/11/2003

Jennifer A. Spinella

General Counsel

01/01/2003

Edward Hu

Corporate Officer/Principal

01/04/1998

01/10/2000

Michael Rudolf

Corporate Officer/Principal

01/01/2000

Michael Kauffman

Chief Tech/Sci/R&D Officer

01/09/1995

01/09/1997

John Alam

Corporate Officer/Principal

01/01/1991

01/01/1997

James L. Vincent

Chief Executive Officer	01/01/1985	01/01/1997
Chairman	01/01/1985	01/01/1997

Steven D. Ertel

Corporate Officer/Principal

Maurice J. Mezzino

Corporate Officer/Principal

Roy R. Lobb

Corporate Officer/Principal

Michael Nourie

Corporate Officer/Principal

Steve Johnson

Corporate Officer/Principal

Russell C. Petter

Corporate Officer/Principal

Juswinder Singh

Corporate Officer/Principal

Edgar H. Ulm

Chief Tech/Sci/R&D Officer

Jennifer Neiman

Public Communications Contact

05/06/2009

Richard Hoey

Corporate Officer/Principal

Paul Chinn

Corporate Officer/Principal

Amy Cohen

Corporate Officer/Principal

Paul A. Foster

Corporate Officer/Principal

Nabil Hanna

Chief Tech/Sci/R&D Officer

Thomas J. Bucknum

General Counsel

Oscar V. Velastegui

Corporate Officer/Principal

Randy Maddux

Corporate Officer/Principal

Raymond G. Arner

General Counsel

C. Eric Schwartz

Corporate Officer/Principal

Naomi Aoki

Public Communications Contact

Katrine Bosley

Corporate Officer/Principal

Linda M. Robertson

General Counsel

David N. Cordo

Corporate Officer/Principal

Timothy P. Linkkila

General Counsel

Kjell Rensfeldt

Corporate Officer/Principal

Edward Rodriguez

Comptroller/Controller/Auditor

Joe Yacano

Corporate Officer/Principal

Jack Giese

Corporate Officer/Principal

Emily Bulat

Corporate Officer/Principal

Gary Payton

Corporate Officer/Principal

Tanji Goodfellow

Corporate Officer/Principal

Steven J. Chartier

Corporate Officer/Principal

Damon Demady

Corporate Officer/Principal

Distribuzione dell'età dei dirigenti

Parità di genere

Uomo	22
Donna	6

Di cui Comitato esecutivo

Uomo	8
Donna	3

Di cui Direttori

Uomo	10
Donna	2

Revisioni

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Biogen Inc. è uno dei leader mondiali nella progettazione, produzione e commercializzazione di prodotti terapeutici. Le vendite nette sono suddivise per fonte di reddito come segue: - vendite di farmaci (74,6%): per il trattamento della sclerosi multipla, della psoriasi cronica negli adulti, dell'artrite reumatoide, dei tumori, ecc; - royalties (6,7%) ; - altro (18,7%): principalmente ricavi da accordi di partnership.

Dipendenti

7.500

Settore

Prodotti farmaceutici

Calendario

06/05 - Q1 2026 Pubblicazione dei risultati (proiezione)

Altre informazioni sulla società